MR. EVAN THOMAS HALL
Prescription History 1306102413
Internal Medicine - Medical Oncology in Seattle, WA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MR. EVAN THOMAS HALL, an active Medical Oncology specialist practicing in Seattle, WA. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 22 documented patient claims. Among these therapy options, the most frequently utilized medication is Amlodipine Besylate, which accounts for 11 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other WA PrescribersVs. WA Avg |
|---|---|---|---|
| Amlodipine Besylate | 11 | $2.60▼ below WA avg | ▼ Less than typical |
About Amlodipine Besylate: Amlodipine is used with or without other medications to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Amlodipine belongs to a class of drugs known as calcium channel blockers. It works by relaxing blood vessels so blood can flow more easily. Amlodipine is also used to prevent certain types of chest pain (angina). It may help to increase your ability to exercise and decrease the frequency of angina attacks. It should not be used to treat attacks of chest pain when they occur. Use other medications (such as sublingual nitroglycerin) to relieve attacks of chest pain as directed by your doctor. A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION. In 2023, this provider wrote 11 Medicare prescriptions for Amlodipine Besylate, about 11% of the volume of the typical Washington prescriber of this medication (97). Medicare paid an average of $2.60 per fill, versus $8.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| CabometyxCabozantinib S-Malate | 11 | $26,709.86 | ▼ Less than typical |
About Cabometyx: This medication is used to treat various types of cancer (including kidney, thyroid, liver cancer). Show more ▾ Cabozantinib belongs to a class of drugs known as tyrosine kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 11 Medicare prescriptions for Cabometyx, about half the volume of the typical Washington prescriber of this medication (20). Medicare paid an average of $26,709.86 per fill, versus $22,705.25 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 328 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for MR. EVAN THOMAS HALL is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Medical Oncology prescribing approach at this Seattle, WA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among WA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
